Open vs. Blind Weighing for Eating Disorders
Trial Summary
What is the purpose of this trial?
Current treatments for adolescents and young adults (AYAs) with eating disorders (EDs) do not effectively address a central ED symptom - anxiety about weight gain - which contributes to poor outcomes. The proposed study evaluates the feasibility, acceptability, efficacy, and underlying mechanisms of an enhanced version of "open weighing," a cognitive-behavioral intervention designed to target anxiety about weight gain in AYAs with EDs. Understanding how to better treat AYAs with EDs, and identifying the mechanisms by which interventions lead to improvement, will aid in the development of more effective and personalized treatments, ultimately improving the lives of AYAs with EDs.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Blind weighing, Blind weighing, Discreet weighing, Open weighing, Open Weighing, Cognitive-Behavioral Intervention for Weight Anxiety?
Is blind weighing safe for individuals with eating disorders?
How does the treatment of blind weighing differ from other treatments for eating disorders?
Blind weighing is unique because it involves not sharing weight data with patients, which can reduce anxiety and concern about weight compared to open weighing, where patients are informed of their weight. This approach may be safer for monitoring weight in individuals with eating disorders, as it can decrease the urge to engage in weight-controlling behaviors.13578
Research Team
Jamal Essayli, Ph.D
Principal Investigator
Penn State University
Eligibility Criteria
This trial is for English-speaking adolescents and young adults aged 12-24 with eating disorders like anorexia nervosa or bulimia, who are anxious about weight gain. They must be admitted to the Partial Hospital Program at Penn State Hershey. It's not for those under 12 or over 24, non-English speakers, people with cognitive impairments, or those without anxiety about weight gain.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either open weighing or blind weighing interventions to address anxiety about weight gain
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Blind weighing (Behavioral Intervention)
- Open weighing (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Milton S. Hershey Medical Center
Lead Sponsor
Dr. Robert Harbaugh
Milton S. Hershey Medical Center
Chief Medical Officer since 2024
MD from Penn State College of Medicine
Don McKenna
Milton S. Hershey Medical Center
Chief Executive Officer since 2024
Master’s in Public Administration and Bachelor of Science in Business Administration and Marketing from Long Island University